Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, indicating a post-release adjustment to the page template or documentation. This represents a small internal update rather than any change to the study information presented.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now states recruitment is closed with a new 'No longer looking for participants' notice and adds navigation/help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). It also updates the Intervention/Treatment label formatting and includes a site revision note 'Revision: v3.6.0' (replacing 'Revision: v3.5.5').SummaryDifference0.4%

- Check23 days agoChange DetectedFooter branding and links were updated to reflect the sponsor and related trial site, and the page revision tag was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check30 days agoChange DetectedPublications section was added, including a citation for a Nat Commun article and notes that publications are automatically filled from PubMed, signaling new study outputs. Several footer/branding items ('Moffitt Cancer Center Clinical Trials website', 'H. Lee Moffitt Cancer Center and Research Institute', 'Helpful Links Provided by') were removed.SummaryDifference0.4%

- Check45 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's metadata.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s release/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site or system revision rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.